Admission BNP as a Dominant Prognostic Signal in Acute Decompensated Heart Failure with Frequent Renal Dysfunction:...

Area of Science:

• Cardiology
• Nephrology
• Biomarkers

Background:

• Risk stratification for acute decompensated heart failure (ADHF) is challenging, especially with concurrent renal dysfunction.
• B-type natriuretic peptide (BNP) is a key biomarker, but its prognostic role in cardiorenal dysfunction needs further characterization.

Purpose of the Study:

• To evaluate the prognostic significance of admission biomarkers, including BNP, for in-hospital mortality in ADHF patients with renal dysfunction.
• To assess the performance of a multivariable model incorporating BNP for predicting outcomes in this high-risk population.

Main Methods:

• Retrospective cohort study of 220 ADHF admissions.
• Developed a multivariable logistic regression model using admission data (age, sex, BP, eGFR, albumin, log-BNP).
• Evaluated model performance using discrimination (AUC) and calibration, adhering to TRIPOD guidelines.

Main Results:

• In-hospital mortality was 7.7%.
• Log-transformed BNP was the sole significant independent predictor of in-hospital mortality (OR 2.39, p=0.009).
• Exploratory model showed an AUC of 0.81 (0.73 after correction); simplified model (albumin, log-BNP) had an AUC of 0.77.

Conclusions:

• Admission BNP is the primary prognostic factor for in-hospital mortality in ADHF patients with renal dysfunction.
• The study's findings are hypothesis-generating due to the limited number of events.
• External validation in larger cohorts is essential for clinical application.